Heart Disease Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who are older than 21 years of age
- People who are 50 years old or younger, regardless of whether they have cardiovascular risk factors (such as high blood pressure, high cholesterol, diabetes, obesity, or being a current smoker) at the time of their heart attack, OR people aged 51 to 60 years old who had no more than 2 of those risk factors (not counting diabetes) at the time of their heart attack
- People who are able to give their informed consent to participate
- People who are willing and able to attend study visits and follow the study procedures
- People who have previously had a Type 1 heart attack, where imaging (via angiogram or CT scan) confirmed a significant blockage — at least 50% in the left main artery, or at least 70% in another major heart artery
- People who identify as one of the three main racial groups in this study: Chinese, Malay, or Indian (self-identified)
Who may not be able to join:
- People who have a known inherited condition causing very high cholesterol (familial hypercholesterolaemia), known blood vessel inflammation conditions (vasculitides), end-stage kidney disease, or a congenital heart condition present from birth
- People who have a history of peripheral artery disease (poor circulation in the limbs) or stroke
- People who are pregnant at the time of the study
- People who are not of Asian background
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Jonathan Yap, National Heart Centre Singapore
Phone: 67042227
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
To identify novel gene variants associated with the onset of MI in relatively young patients
Can't join this trial?
Data last synced from ClinicalTrials.gov: 14 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.